HKD 0.89
(-2.2%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 7.44 Billion CNY | -5.95% |
2022 | 7.92 Billion CNY | -1.54% |
2021 | 8.04 Billion CNY | -1.34% |
2020 | 8.15 Billion CNY | 329.44% |
2019 | 1.89 Billion CNY | 258.71% |
2018 | 529.33 Million CNY | 161.53% |
2017 | 202.4 Million CNY | 98.78% |
2016 | 101.82 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 7.18 Billion CNY | 0.0% |
2023 Q4 | 7.44 Billion CNY | 0.0% |
2023 FY | 7.44 Billion CNY | -5.95% |
2023 Q2 | 8.14 Billion CNY | 0.0% |
2022 FY | 7.92 Billion CNY | -1.54% |
2022 Q4 | 7.92 Billion CNY | 0.0% |
2022 Q2 | 8.15 Billion CNY | 0.0% |
2021 Q2 | 7.9 Billion CNY | 0.0% |
2021 FY | 8.04 Billion CNY | -1.34% |
2021 Q4 | 8.04 Billion CNY | 0.0% |
2020 Q4 | 8.15 Billion CNY | 0.0% |
2020 FY | 8.15 Billion CNY | 329.44% |
2020 Q2 | 3.29 Billion CNY | 0.0% |
2019 Q4 | 1.89 Billion CNY | 0.0% |
2019 Q2 | 1.81 Billion CNY | 0.0% |
2019 FY | 1.89 Billion CNY | 258.71% |
2018 Q4 | 529.33 Million CNY | 0.0% |
2018 FY | 529.33 Million CNY | 161.53% |
2017 FY | 202.4 Million CNY | 98.78% |
2016 FY | 101.82 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -1717.087% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 33.763% |